SLC1A5 and neoplasm: Therefore, the current study investigates the inconsistent activities of GLS1 inhibitors observed in in vitro and in vivo studies and proposes a novel approach: simultaneous targeting of tumor glutamine transport (ASCT2) and glutamine metabolism (GLS1).